ResMed Announces Participation in the Credit Suisse 30th Annual Healthcare Conference
ResMed (NYSE: RMD) announced that CEO Mick Farrell will participate in a virtual fireside chat at the Credit Suisse 30th Annual Healthcare Conference on November 10, 2021, at approximately 1:00 p.m. EST.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
ResMed (NYSE: RMD) announced that CEO Mick Farrell will participate in a virtual fireside chat at the Credit Suisse 30th Annual Healthcare Conference on November 10, 2021, at approximately 1:00 p.m. EST. The event will be accessible via video webcast, with a replay available 24 hours post-event until February 8, 2021. ResMed focuses on innovative healthcare solutions, particularly in digital health technologies and cloud-connected medical devices for chronic diseases.
Details
News Market Reaction – RMD
The recorded move for RMD in the trading session of this news was +2.10%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
SAN DIEGO, Nov. 03, 2021 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, chief executive officer, will participate in a virtual fireside chat at the Credit Suisse 30th Annual Healthcare Conference on Wednesday, November 10, 2021, beginning at approximately 1:00 p.m. (Eastern Standard Time) via video webcast.
More information about this event, including access to the live webcast, may be accessed by visiting https://investor.resmed.com. The webcast replay will be available approximately 24 hours after the live webcast ends and will be accessible through February 8, 2021.
About ResMed
At ResMed (NYSE: RMD, ASX: RMD) we pioneer innovative solutions that treat and keep people out of the hospital, empowering them to live healthier, higher-quality lives. Our digital health technologies and cloud-connected medical devices transform care for people with sleep apnea, COPD, and other chronic diseases. Our comprehensive out-of-hospital software platforms support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. By enabling better care, we improve quality of life, reduce the impact of chronic disease, and lower costs for consumers and healthcare systems in more than 140 countries. To learn more, visit ResMed.com and follow @ResMed.
| For investors | For media |
| Amy Wakeham | Jayme Rubenstein |
| +1 858.836.5000 | +1 858.836.6798 |
| investorrelations@resmed.com | news@resmed.com |
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.